Cargando...
Immune checkpoint inhibitors in esophageal squamous cell carcinoma: progress and opportunities
Esophageal squamous cell carcinoma (ESCC) is one of the common malignant tumors in the world. More than half of patients with ESCC were detected in advanced or metastatic disease at the time of initial diagnosis and lost the opportunities of surgery. Currently, surgical resection, radiotherapy, and...
Guardado en:
| Publicado en: | Onco Targets Ther |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Dove
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6677374/ https://ncbi.nlm.nih.gov/pubmed/31551657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S214579 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|